Abstract
Lung cancer is the most incident tumor worldwide and the most lethal. Screening programs have been implemented worldwide in an attempt to reduce lung cancer mortality rates. Currently, strategies based on the analysis of body fluids (liquid biopsy) are being increasingly used, however, the application of this type of analysis in screening programs remains incipient. The detection of free …